Skip to main content
Clinical Trials/NL-OMON56628
NL-OMON56628Not yet recruitingPhase 2

Preoperative Accelerated Partial Breast Irradiation in patients with locally recurrent or second primary breast cancer - PAPBI-3

Antoni van Leeuwenhoek Ziekenhuis0 sites31 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
31

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Female patients >= 51 years
  • Ipsilateral breast cancer; recurrence or second primary
  • Histologically proven invasive adenocarcinoma
  • Histologically proven estrogen receptor positive, HER2-negative
  • Tumor size <= 3 cm
  • Grade I or grade II (biopsy)
  • Unifocal lesions on mammogram and MRI
  • Interval since completion of local treatment of primary tumor > 12 months
  • Previous radiotherapy (whole breast or partial) of the ipsilateral breast
  • Repeat breast conserving surgery feasible

Exclusion Criteria

  • >= grade 3 radiotherapy toxicity in the breast
  • Previous boost radiotherapy is not allowed, UNLESS the protocol tumor lies
  • outside of the original boost area
  • Distant metastases and/or synchronous contralateral invasive or in situ
  • Lobular invasive carcinoma or pleiomorph LCIS
  • Pure DCIS
  • Triple negative or HER2neu positive subtype
  • Lymphovascular invasion in biopsy
  • Neoadjuvant systemic treatment for the protocol tumor (except for admission
  • of pre-surgery hormonal therapy <= 2 months)

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Similar Trials

Preoperative Accelerated Partial Breast... | Clinical Trial